Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: A randomized, phase 2 clinical trial in Thailand

Clinical Infectious Diseases

Volumn 43, Issue 10, 2006, Pages 1264-1271

  Noedl, Harald ^a,c   Krudsood, Srivicha ^b   Chalermratana, Kobsiri ^b   Silachamroon, Udomsak ^b   Leowattana, Wattana ^b   Tangpukdee, Noppadon ^b   Looareesuwan, Sornchai ^b   Miller, Robert Scott ^a   Fukuda, Mark ^a   Jongsakul, Krisada ^a   Sriwichai, Sabaithip ^a   Rowan, Jacqueline ^d   Bhattacharyya, Helen ^d   Ohrt, Colin ^e   Knirsch, Charles ^d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d PFIZER INC   (United States)

^e WRAIR   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTESUNATE; AZITHROMYCIN; CHLOROQUINE; DIHYDROARTEMISININ; DIMENHYDRINATE; MACROLIDE; MEFLOQUINE; PARACETAMOL; QUININE;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS RESISTANCE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG SENSITIVITY; ECG ABNORMALITY; FEMALE; FEVER; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HOSPITAL PATIENT; HUMAN; IN VITRO STUDY; LOW DRUG DOSE; LYMPHATIC SYSTEM DISEASE; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; OPEN STUDY; PHASE 2 CLINICAL TRIAL; PLASMODIUM FALCIPARUM; PREGNANCY; PRIORITY JOURNAL; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL; TABLET; THAILAND; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; UROGENITAL TRACT DISEASE;

ADULT; ANIMALS; ANTIMALARIALS; ARTEMISININS; AZITHROMYCIN; CHILD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALARIA, FALCIPARUM; PREGNANCY; QUININE; SESQUITERPENES;

EID: 33750682726     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/508175     Document Type: Article

References (26)

1. Noedl H, Wernsdorfer WH, Krudsood S, et al. Antimalarial activity of azithromycin, artemisinin and dihydroartemisinin in fresh isolates of Plasmodium falciparum in Thailand. Acta Trop 2001; 80:39-44.
2. Ohrt C, Willingmyre GD, Lee P, Knirsch C, Milhous W. Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro. Antimicrob Agents Chemother 2002; 46:2518-24.
3. Andersen SL, Oloo AJ, Gordon DM, et al. Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in western Kenya. Clin Infect Dis 1998; 26:146-50.
4. Taylor W, Richie T, Fryauff D, et al. Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia. Clin Infect Dis 1999; 28:74-81.
5. Dunne MW, Singh N, Shukla M, et al. A multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodium falciparum malaria in India. J Infect Dis 2005; 191:1582-8.
6. Miller RS, Wongsrichanalai C, Buathong N, et al. Effective treatment of uncomplicated Plasmodium falciparum malaria with azithromycinquinine combinations: a randomized, dose-ranging study. Am J Trop Med Hyg 2006; 74:401-6.
7. Heppner DG Jr, Walsh DS, Uthaimongkol N, et al. Randomized, controlled double-blind trial of daily oral azithromycin in adults for the prophylaxis of Plasmodium vivax malaria in western Thailand. Am J Trop Med Hyg 2005; 73:842-9.
8. Gray RH, Wabwire-Mangen F, Kigozi G, et al. Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. Am J Obstet Gynecol 2001; 185:1209-17.
9. World Health Organization. Chemotherapy of malaria and resistance to antimalarials: report of a WHO scientific group. WHO Technical Report Series, no. 529. Geneva, Switzerland: WHO, 1973.
10. Noedl H, Attlmayr B, Wernsdorfer WH, Kollaritsch H, Miller RS. A histidine-rich protein 2-based malaria drug sensitivity assay for field use. Am J Trop Med Hyg 2004; 71:711-4.
11. Noedl H, Bronnert J, Yingyuen K, Attlmayr B, Kollaritsch H, Fukuda M. Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing. Antimicrob Agents Chemother 2005; 49:3575-7.
12. Clopper CJ, Pearson ES. The use of confidence of fiducial limits illustrated in the case of the binomal. Biometrika 1934; 26:404-13.
13. Vijaykadga S, Rojanawatsirivej C, Cholpol S, Phoungmanee D, Nakavej A, Wongsrichanalai C. In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003. Trop Med Int Health 2006; 11:211-9.
14. Francis D, Nsobya SL, Talisuna A, et al. Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance. J Infect Dis 2006; 193:978-86.
15. Menard D, Matsika-Claquin MD, Djalle D, et al. Association of failures of seven-day courses of artesunate in a non-immune population in Bangui, Central African Republic with decreased sensitivity of Plasmodium falciparum. Am J Trop Med Hyg 2005; 73:616-21.
16. Batt SL, Charalarnbous BM, Solomon AW, et al. Impact of azithromycin administration for trachoma control on the carriage of antibiotic-resistant Streptococcus pneumonias. Antimicrob Agents Chemother 2003; 47:2765-9.
17. Gaynor BD, Holbrook KA, Whitcher JP, et al. Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year. Br J Ophthalmol 2003; 87:147-8.
18. Gladue RP, Snider ME. Intracellular accumulation of azithromycin by cultured human fibroblasts. Antimicrob Agents Chemother 1990; 34:1056-60
19. (erratum: Antimicrob Agents Chemother 1990; 34:2041).
20. Gladue RP, Bright GM, Isaacson RE, Newborg MF. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob Agents Chemother 1989; 33:277-82.
21. Krudsood S, Buchachart K, Chalermrut K, et al. A comparative clinical trial of combinations of dihydroartemisinin plus azithromycin and dihydroartemisinin plus mefloquine for treatment of multidrug resistant falciparum malaria. Southeast Asian J Trop Med Public Health 2002; 33:525-31.
22. Karbwang J, Davis TM, Looareesuwan S, Molunto P, Bunnag D, White NJ. A comparison of the pharmacokinetic and pharmacodynamic properties of quinine and quinidine in healthy Thai males. Br J Clin Pharmacol 1993; 35:265-71.
23. Brockman A, Price R, van Vugt M, et al. Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine. Trans R Soc Trop Med Hyg 2000; 94:537-44.
24. White NJ, Nosten F, Looareesuwan S, et al. Averting a malaria disaster. Lancet 1999; 353:1965-7.
25. Reyburn H, Mbatia R, Drakeley C, et al. Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ 2004; 329:1212.
26. Frenck RW Jr, Mansour A, Nakhla I, et al. Short-course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents. Clin Infect Dis 2004; 38:951-7.